Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus

Glucagon-like peptide-1 (GLP-1) receptor agonists are recently discovered antidiabetic drugs with potent hypoglycemic effects. Among different mechanisms of activity, these compounds were shown to reduce blood glucose by suppression of glucagon secretion and stimulation of glucose-dependent insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaribeygi, Habib, Atkin, Stephen L., Montecucco, Fabrizio, Jamialahmadi, Tannaz, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405289/
https://www.ncbi.nlm.nih.gov/pubmed/34471642
http://dx.doi.org/10.1155/2021/8163153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405289/
https://www.ncbi.nlm.nih.gov/pubmed/34471642
http://dx.doi.org/10.1155/2021/8163153

Ejemplares similares